🇺🇸 FDA
Patent

US 8809377

Deubiquitinase inhibitors and methods for use of the same

granted A61PA61P1/04A61P1/16

Quick answer

US patent 8809377 (Deubiquitinase inhibitors and methods for use of the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/00, A61P21/00